All the pieces needed to accelerate smoking cessation in the US and increase the number of therapeutic products with the indication are in place if the Biden administration is ready to act, says a former tobacco programs chief for the Food and Drug Administration.
The pieces, says Mitch Zeller, include a commitment from the White House to requiring a reduction in nicotine levels allowed in tobacco products and movement by the FDA on finalizing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?